Xiao X. Wei

3.5k total citations
85 papers, 1.7k citations indexed

About

Xiao X. Wei is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Xiao X. Wei has authored 85 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 48 papers in Oncology and 22 papers in Surgery. Recurrent topics in Xiao X. Wei's work include Cancer Immunotherapy and Biomarkers (38 papers), Prostate Cancer Treatment and Research (36 papers) and Bladder and Urothelial Cancer Treatments (22 papers). Xiao X. Wei is often cited by papers focused on Cancer Immunotherapy and Biomarkers (38 papers), Prostate Cancer Treatment and Research (36 papers) and Bladder and Urothelial Cancer Treatments (22 papers). Xiao X. Wei collaborates with scholars based in United States, Germany and Canada. Xiao X. Wei's co-authors include Bradley A. McGregor, Toni K. Choueiri, Lauren C. Harshman, Hojjat Ahmadzadehfar, Markus Essler, Lawrence Fong, Eric J. Small, Charles J. Ryan, Rana R. McKay and Stefan Kürpig and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Xiao X. Wei

80 papers receiving 1.7k citations

Peers

Xiao X. Wei

PRM

ONCOL

RNMI

SURGE

Benjamin L. Maughan United States

Youling Gong China

Ulrika Harmenberg Sweden

Tony Elliott United Kingdom

Kaku Saito Japan

Naoki Yanagawa Japan

Yoshinobu Ichiki Japan

Sergi Benavente Spain

Mario Eisenberger United States

K.N. Chi Canada

Benjamin L. Maughan United States

Xiao X. Wei

1.4k ×1.4

PRM

915 ×1.1

ONCOL

294 ×0.6

RNMI

541 ×1.2

266 ×0.8

SURGE

Citations per year, relative to Xiao X. Wei Xiao X. Wei (= 1×) peers Benjamin L. Maughan

Countries citing papers authored by Xiao X. Wei

Since Specialization

Citations

This map shows the geographic impact of Xiao X. Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao X. Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao X. Wei more than expected).

Fields of papers citing papers by Xiao X. Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao X. Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao X. Wei. The network helps show where Xiao X. Wei may publish in the future.

Co-authorship network of co-authors of Xiao X. Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao X. Wei. A scholar is included among the top collaborators of Xiao X. Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao X. Wei. Xiao X. Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jun, Chaozong Liu, Kai Ma, et al.. (2025). Optimizing the anisotropy of Al-Zn-Mg-Cu alloy plates by regulating the rolling step reduction. Materials Science and Engineering A. 929. 148126–148126. 1 indexed citations

Reich, Amanda J., et al.. (2025). Examining Patient Characteristics in Bladder Cancer Clinical Trials Involving Immunotherapy. Journal of Clinical Medicine. 14(3). 879–879.

Heath, Elisabeth I., Neal D. Shore, Daniel J. George, et al.. (2025). Real-world treatment patterns and outcomes in advanced prostate cancer: A cohort study using the prostate cancer disease observation (PRECISION) data platform.. Journal of Clinical Oncology. 43(5_suppl). 59–59.

Ravi, Praful, Wanling Xie, Himisha Beltran, et al.. (2024). Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer. European Urology Oncology. 8(3). 709–715. 1 indexed citations

Ding, Fan, Yuting Liu, Jia Li, et al.. (2024). TC14012 enhances the anti-fibrosis effects of UC-MSCs on the liver by reducing collagen accumulation and ameliorating inflammation. Stem Cell Research & Therapy. 15(1). 44–44. 3 indexed citations

Lyu, Aram, Matthew Clark, Averey Lea, et al.. (2024). Evolution of myeloid-mediated immunotherapy resistance in prostate cancer. Nature. 637(8048). 1207–1217. 44 indexed citations

Choudhury, Atish D., Hyewon Hyun, Emma Kelly, et al.. (2024). Patient outcomes after therapy with ¹⁷⁷Lu-PSMA-617 (LuPSMA) for metastatic castrate-resistant prostate cancer (mCRPC): A tertiary center experience.. Journal of Clinical Oncology. 42(4_suppl). 87–87. 1 indexed citations

McGregor, Bradley A., Guru Sonpavde, Lucia Kwak, et al.. (2023). The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma. Annals of Oncology. 35(1). 91–97. 51 indexed citations

Taylor, Amy K., Jamie M. Sperger, Marina N. Sharifi, et al.. (2023). Association of emergent neuroendocrine prostate cancer detected by liquid biopsies with survival and treatment resistance.. Journal of Clinical Oncology. 41(6_suppl). 247–247. 1 indexed citations

10.

Miyahira, Andrea K., Jessica E. Hawley, Remi Adelaiye‐Ogala, et al.. (2022). Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey−Holden prostate cancer academy meeting. The Prostate. 83(3). 207–226. 2 indexed citations

11.

McKay, Rana R., Lucia Kwak, Jett Crowdis, et al.. (2021). Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance. Clinical Cancer Research. 27(13). 3610–3619. 21 indexed citations

12.

Madan, Ravi A., Susan F. Slovin, Lauren C. Harshman, et al.. (2020). 681P Clinical and immune responses to immunotherapy in biochemically recurrent (non-metastatic castration sensitive) prostate cancer (BCRpc). Annals of Oncology. 31. S542–S542. 1 indexed citations

13.

Scholl, C., Ralph A. Bundschuh, Xiao X. Wei, et al.. (2019). Radionuclide intake risks in the clinical administration of ²²³ RaCl ₂. Journal of Radiological Protection. 39(2). 387–398. 5 indexed citations

14.

Hagihara, Katsunobu, Li Zhang, David Y. Oh, et al.. (2018). Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer. OncoImmunology. 8(1). e1486953–e1486953. 29 indexed citations

15.

Ahmadzadehfar, Hojjat, Simone Wegen, Anna Yordanova, et al.. (2017). Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617. European Journal of Nuclear Medicine and Molecular Imaging. 44(9). 1448–1454. 129 indexed citations

16.

Wei, Xiao X., Emily Chang, Li Zhang, et al.. (2017). Clinical Variables Associated With Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Sipuleucel-T Immunotherapy. Clinical Genitourinary Cancer. 16(3). 184–190.e2. 12 indexed citations

17.

Wei, Xiao X., Carl Diedrich Schlenkhoff, Bettina Schwarz, Markus Essler, & Hojjat Ahmadzadehfar. (2017). Combination of 177Lu-PSMA-617 and External Radiotherapy for the Treatment of Cerebral Metastases in Patients With Castration-Resistant Metastatic Prostate Cancer. Clinical Nuclear Medicine. 42(9). 704–706. 31 indexed citations

18.

Wei, Xiao X., Serena S. Kwek, Jera Lewis, et al.. (2016). Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer. Cancer Immunology Research. 4(11). 948–958. 30 indexed citations

19.

Wei, Xiao X., Lawrence Fong, & Eric J. Small. (2015). Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions. Expert Review of Vaccines. 14(12). 1529–1541. 34 indexed citations

20.

Cai, Houjian, Ivan Babić, Xiao X. Wei, Jiaoti Huang, & Owen N. Witte. (2010). Invasive Prostate Carcinoma Driven by c-Src and Androgen Receptor Synergy. Cancer Research. 71(3). 862–872. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact